Cargando…
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
INTRODUCTION: Primary hyperoxaluria (PH) is a family of 3 rare genetic disorders of hepatic glyoxylate metabolism that lead to overproduction and increased renal excretion of oxalate resulting in progressive renal damage. LDHA inhibition of glyoxylate-to-oxalate conversion by RNA interference (RNAi)...
Autores principales: | Ariceta, Gema, Barrios, Kelly, Brown, Bob D., Hoppe, Bernd, Rosskamp, Ralf, Langman, Craig B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071644/ https://www.ncbi.nlm.nih.gov/pubmed/33912759 http://dx.doi.org/10.1016/j.ekir.2021.01.029 |
Ejemplares similares
-
Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
por: Lai, Chengjung, et al.
Publicado: (2018) -
Clinical and economic impact of primary hyperoxaluria: a retrospective claims analysis
por: Mucha, Lisa, et al.
Publicado: (2022) -
Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria
por: Forbes, Thomas A., et al.
Publicado: (2021) -
Improving Treatment Options for Primary Hyperoxaluria
por: Hoppe, Bernd, et al.
Publicado: (2022) -
ALLN-177, oral enzyme therapy for hyperoxaluria
por: Lingeman, James E., et al.
Publicado: (2019)